Effect of Adiponectin on Kidney Crystal Formation in Metabolic Syndrome Model Mice via Inhibition of Inflammation and Apoptosis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Fujii, Yasuhiro ^a   Okada, Atsushi ^a   Yasui, Takahiro ^a   Niimi, Kazuhiro ^a   Hamamoto, Shuzo ^a   Hirose, Masahito ^a   Kubota, Yasue ^a   Tozawa, Keiichi ^a   Hayashi, Yutaro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CALCIUM OXALATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; CRYSTALLIZATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY CRYSTAL FORMATION; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MOUSE; NEPHROLITHIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN DETERMINATION; PROTEIN FUNCTION; RENAL PROTECTION; STONE FORMATION; UPREGULATION; WILD TYPE;

ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CALCIUM OXALATE; CHEMOKINE CCL2; CHOLESTEROL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; KIDNEY; KIDNEY CALCULI; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, OBESE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; SUPEROXIDE DISMUTASE; TRANSCRIPTOME;

MUS;

EID: 84876425163     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061343     Document Type: Article

References (29)

1. Curhan GC, (2007) Epidemiology of stone disease. Urol Clin North Am 34: 287-293.
2. Yasui T, Iguchi M, Suzuki S, Okada A, Itoh Y, et al. (2008) Prevalence and epidemiologic characteristics of lower urinary tract stones in Japan. Urology 71: 209-213.
3. Coe FL, Parks JH, Asplin JR, (1992) The pathogenesis and treatment of kidney stones-medical Progress. N Engl J Med 327: 1141-1152.
4. Levy FL, Adams-Huet B, Pak CY, (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98: 50-59.
5. Asplin JR, Parks JH, Coe FL, (1997) Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 52: 1602-1608.
6. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, et al. (1993) Structure and expression of the mRNA-encoding urinary stone protein osteopontin. J Biol Chem 268: 15180-15184.
7. Okada A, Nomura S, Higashibata Y, Hirose M, Gao B, et al. (2007) Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res 35: 89-99.
8. Okada A, Nomura S, Saeki Y, Higashibata Y, Hamamoto S, et al. (2008) Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23: 1629-1637.
9. Hirose M, Tozawa K, Okada A, Hamamoto S, Shimizu H, et al. (2008) Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res 36: 139-147.
10. Taylor EN, Stampfer MJ, Curhan GC, (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293: 455-462.
11. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K, (2004) The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int 65: 386-392.
12. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, et al. (1999) Essential arterial hypertension and stone disease. Kidney Int 55: 2397-2406.
13. Yasui T, Itoh Y, Bing G, Okada A, Tozawa K, et al. (2007) Aortic calcification in urolithiasis patients. Scand J Urol Nephrol 41: 419-421.
14. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) Replenishment of the fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 7: 941-946.
15. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, et al. (2002) Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 277: 37487-37491.
16. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
17. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, et al. (2007) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27: 1910-1919.
18. Fischer S, Maclean AA, Liu M, Cardella JA, Slutsky AS, et al. (2000) Dynamic Changes in Apoptotic and Necrotic Cell Death Correlate with Severity of Ischemia-Reperfusion Injury in Lung Transplantation. Am J Respir Crit Care Med 162: 1932-1939.
19. Curhan GC, Taylor EN, (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73: 489-496.
20. Byer K, Khan SR, (2005) Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 173: 640-646.
21. Pucci ML, Endo S, Nomura T, Lu R, Khine C, et al. (2006) Coordinate control of prostaglandin E2 synthesis and uptake by hyperosmolarity in renal medullary interstitial cells. Am J Physiol Renal Physiol 290: F641-649.
22. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 16: 286-289.
23. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, et al. (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279: 30817-30822.
24. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103.
25. Okada A, Yasui T, Fujii Y, Niimi K, Hamamoto S, et al. (2010) Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation. J Bone Miner Res 25: 2701-2711.
26. Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, et al. (2009) Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res 24: 908-924.
27. Dar AA, Belkhiri A, Ecsedy J, Zaika A, El-Rifai W, (2008) Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res 68: 8998-9004.
28. Jeong MH, Jin YH, Kang EY, Jo WS, Park HT, et al. (2004) The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1. Cell Res 14: 295-302.
29. Onaran M, Yilmaz A, Sen I, Ergun MA, Camtosun A, et al. (2009) A HindIII polymorphism of fibronectin gene is associated with nephrolithiasis. Urology 74: 1004-1007.